SUDEEP PHARMA
Back to Balance Sheet
|
SUDEEP PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹175 Cr | ₹137 Cr | ₹171 Cr | ₹147 Cr | ₹80 Cr |
What is the latest Total Current Liabilities ratio of SUDEEP PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹175 Cr |
| Mar2024 | ₹137 Cr |
| Mar2023 | ₹171 Cr |
| Mar2022 | ₹147 Cr |
| Mar2021 | ₹80 Cr |
How is Total Current Liabilities of SUDEEP PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹175 Cr | 27.35 | |
| Mar2024 | ₹137 Cr | -19.67 | |
| Mar2023 | ₹171 Cr | 16.23 | |
| Mar2022 | ₹147 Cr | 84.20 | |
| Mar2021 | ₹80 Cr | - | |
Compare Total Current Liabilities of peers of SUDEEP PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUDEEP PHARMA | ₹9,605.5 Cr | -3.6% | 25.1% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,803.0 Cr | 2.6% | 1.2% | 13% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,219.0 Cr | 1.3% | -2.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹152,417.0 Cr | 1.5% | 0.7% | 37.1% | Stock Analytics | |
| CIPLA | ₹116,116.0 Cr | 6.1% | 2.4% | -5.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,874.0 Cr | 2.6% | -0.4% | -2.1% | Stock Analytics | |
SUDEEP PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUDEEP PHARMA | -3.6% |
25.1% |
|
| SENSEX | -0.2% |
2.1% |
-5.6% |
You may also like the below Video Courses